Reporter brief
Injectable klotho-follistatin plasmid gene therapy assessed for safety in healthy adults in uncontrolled pilot study
What happened
This pilot study investigated the safety and efficacy of a combination klotho and follistatin gene therapy delivered via nonviral plasmid injection in healthy adult volunteers. The study sought to evaluate both safety outcomes and potential cognitive and health benefits, though no specific results are reported in the abstract.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Observational; Human.
healthy adult volunteers
- Design
- Observational
- Sample
- —
- Journal
- Minicircle
- Published
- Aug 27, 2026
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Klotho timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.